Atlas Trials

The DAWN Antivirals Trial for Ambulatory COVID-19 Patients

Clinical trial NCT04730206 · TERMINATED

Trial details

NCT number
NCT04730206
Sponsor
KU Leuven
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19SARS-CoV Infection
Start date
2021-06-15
Primary completion
2022-07-13
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.